KalVista Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2013 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
KalVista Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2013 to Q1 2024.
  • KalVista Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending April 30, 2024 was $58.5M, a 29.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $58.5M +$13.3M +29.3% Apr 30, 2024 10-K 2024-07-11
Q1 2023 $45.3M +$17.1M +60.5% Apr 30, 2023 10-K 2024-07-11
Q1 2022 $28.2M +$11.2M +65.7% Apr 30, 2022 10-K 2023-07-10
Q1 2021 $17M +$7.5M +78.7% Apr 30, 2021 10-K 2022-07-07
Q1 2020 $9.53M +$1.14M +13.5% Apr 30, 2020 10-K 2021-07-13
Q1 2019 $8.39M +$1.56M +22.8% Apr 30, 2019 10-K 2020-07-01
Q1 2018 $6.84M +$952K +16.2% Apr 30, 2018 10-K 2019-07-16
Q1 2017 $5.88M +$3.04M +107% Apr 30, 2017 10-K 2018-07-30
Q1 2016 $2.85M Apr 30, 2016 10-K 2017-07-27
Q4 2015 $28.8M +$10.5M +57.8% Dec 31, 2015 10-K 2016-03-30
Q4 2014 $18.2M +$3.98M +27.9% Dec 31, 2014 10-K 2016-03-30
Q4 2013 $14.3M Dec 31, 2013 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.